{"transactions":[{"id":736286,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T22:32:48.000Z","date":"2026-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5415,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.2565,"underlying":"Common Stock","underlying_shares":5415},"source":{"system":"sec-edgar","filing":"0001104659-26-074749","document":"tm2618077-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074749/tm2618077-6_4seq1.xml","form_type":"4"}},{"id":736285,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T22:32:48.000Z","date":"2026-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5415,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":15.15,"underlying":"Common Stock","underlying_shares":5415},"source":{"system":"sec-edgar","filing":"0001104659-26-074749","document":"tm2618077-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074749/tm2618077-6_4seq1.xml","form_type":"4"}},{"id":736284,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T22:32:48.000Z","date":"2026-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1753,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":16.05,"underlying":"Common Stock","underlying_shares":1753},"source":{"system":"sec-edgar","filing":"0001104659-26-074749","document":"tm2618077-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074749/tm2618077-6_4seq1.xml","form_type":"4"}},{"id":736283,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T22:32:48.000Z","date":"2026-06-16","kind":"other","planned":false,"acquired":false,"shares":23855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the \"Issuer\"), Zydus Worldwide DMCC (\"Parent\"), Zara Merger Sub Inc., a wholly owned subsidiary of Parent (\"Purchaser\") and Zydus Pharmaceuticals (USA) Inc., pursuant to which Purchaser completed a tender offer (the \"Offer\") for all outstanding shares of common stock of the Issuer (\"Company Common Stock\") at a price of $23.50 per share in cash, without interest (the \"Offer Price\"), and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"), effective as of June 16, 2026 (the \"Effective Time\"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right [continues to Footnote 2]"},{"field":"shares","element":"transactionShares","label":"F2","text":"[continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F3","text":"Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a \"Company RSU\") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each outstanding Company RSU was cancelled and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-074749","document":"tm2618077-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074749/tm2618077-6_4seq1.xml","form_type":"4"}},{"id":790002,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-06T22:05:09.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":4851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2026 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 26, 2025, the Issuer effected a 1-for-15 reverse stock split (the \"Reverse Stock Split\"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":23855,"source":{"system":"sec-edgar","filing":"0001104659-26-056415","document":"tm2613761-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926056415/tm2613761-1_4seq1.xml","form_type":"4"}},{"id":819693,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T21:16:13.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":31750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":105456,"source":{"system":"sec-edgar","filing":"0001193125-26-140513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526140513/ownership.xml","form_type":"4"}},{"id":879184,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-02-26T21:30:04.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":42945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/36th of the shares subject to the option shall vest on each monthly anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":42945,"derivative":{"exercise_price":7.95,"expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":42945},"source":{"system":"sec-edgar","filing":"0001193125-26-076897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1897662/000119312526076897/ownership.xml","form_type":"4"}},{"id":879183,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T21:30:04.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":11006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award of common stock and 1/3rd of the shares underlying the restricted stock unit award shall vest on each one-year anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":11006,"source":{"system":"sec-edgar","filing":"0001193125-26-076897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1897662/000119312526076897/ownership.xml","form_type":"4"}},{"id":925241,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T21:05:13.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":63500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date."}],"balance_after":63500,"derivative":{"exercise_price":27.62,"expiration_date":"2036-01-31","underlying":"Common Stock","underlying_shares":63500},"source":{"system":"sec-edgar","filing":"0001193125-26-033603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526033603/ownership.xml","form_type":"4"}},{"id":951670,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:16:08.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":6294,"price":27.1,"value":170567.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on December 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025."}],"balance_after":73706,"source":{"system":"sec-edgar","filing":"0001193125-26-002448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526002448/ownership.xml","form_type":"4"}},{"id":1153827,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-09T22:01:45.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":81225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2025 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":81225,"derivative":{"exercise_price":0.6171,"expiration_date":"2035-05-07","underlying":"Common Stock","underlying_shares":81225},"source":{"system":"sec-edgar","filing":"0001104659-25-046868","document":"tm2514518-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925046868/tm2514518-1_4seq1.xml","form_type":"4"}},{"id":1153826,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:01:45.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":53750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2025 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":285070,"source":{"system":"sec-edgar","filing":"0001104659-25-046868","document":"tm2514518-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925046868/tm2514518-1_4seq1.xml","form_type":"4"}},{"id":1318721,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T01:04:15.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option vests as to 25% on the first anniversary of the vesting commencement date, December 31, 2024, and at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":160000,"derivative":{"exercise_price":24.8,"expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000950170-25-000624","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025000624/ownership.xml","form_type":"4"}},{"id":1318720,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-03T01:04:15.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan (the \"Plan\"). Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSU vests in four substantially equal installments on each of the first four anniversaries of December 31, 2024, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0000950170-25-000624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025000624/ownership.xml","form_type":"4"}},{"id":1357111,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO and CFO"}}],"security":"Class A Common Stock","published_at":"2024-11-20T21:05:03.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":11001,"price":4.08,"value":44884.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":309572,"source":{"system":"sec-edgar","filing":"0000950170-24-129227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024129227/ownership.xml","form_type":"4"}},{"id":1500533,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-29T00:02:22.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":81225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2024 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":81225,"derivative":{"exercise_price":1.01,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":81225},"source":{"system":"sec-edgar","filing":"0001104659-24-065701","document":"tm2415689-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924065701/tm2415689-5_4seq1.xml","form_type":"4"}},{"id":1500532,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T00:02:22.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":53750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2024 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":231320,"source":{"system":"sec-edgar","filing":"0001104659-24-065701","document":"tm2415689-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924065701/tm2415689-5_4seq1.xml","form_type":"4"}},{"id":1508892,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-20T20:05:24.000Z","date":"2024-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":18280,"price":6.64,"value":121379.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units."}],"balance_after":320573,"source":{"system":"sec-edgar","filing":"0000950170-24-062372","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024062372/ownership.xml","form_type":"4"}},{"id":1580938,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-03-12T20:05:21.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":37120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":37120},"source":{"system":"sec-edgar","filing":"0000950170-24-029907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024029907/ownership.xml","form_type":"4"}},{"id":1580937,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-12T20:05:21.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":37120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted on March 8, 2023. The earned PSUs were certified on February 12, 2024, and March 7, 2024, and vested on March 8, 2024."}],"balance_after":338853,"source":{"system":"sec-edgar","filing":"0000950170-24-029907","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024029907/ownership.xml","form_type":"4"}},{"id":1591488,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-06T21:05:12.000Z","date":"2024-03-04","kind":"purchase","planned":false,"acquired":true,"shares":10684,"price":9.38,"value":100215.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.37 to $9.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":301733,"source":{"system":"sec-edgar","filing":"0000950170-24-027128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024027128/ownership.xml","form_type":"4"}},{"id":1643042,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-02-15T01:39:29.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":32656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."}],"balance_after":32656,"derivative":{"expiration_date":"2027-02-28","underlying":"Class A Common Stock","underlying_shares":32656},"source":{"system":"sec-edgar","filing":"0000950170-24-015545","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024015545/ownership.xml","form_type":"4"}},{"id":1643041,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-15T01:39:29.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":65312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":291049,"source":{"system":"sec-edgar","filing":"0000950170-24-015545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024015545/ownership.xml","form_type":"4"}},{"id":1649076,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-12T21:05:21.000Z","date":"2024-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":41332,"price":14.9,"value":615846.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units and restricted stock units."}],"balance_after":225737,"source":{"system":"sec-edgar","filing":"0000950170-24-013817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024013817/ownership.xml","form_type":"4"}},{"id":1675122,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-19T21:05:14.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted December 6, 2021. The earned PSUs were certified and vested on January 17, 2024."}],"balance_after":267069,"source":{"system":"sec-edgar","filing":"0001209191-24-001903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919124001903/doc4.xml","form_type":"4"}},{"id":1734409,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-20T21:05:22.000Z","date":"2023-11-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":6661,"price":9.44,"value":62879.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":182069,"source":{"system":"sec-edgar","filing":"0001209191-23-056023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123056023/doc4.xml","form_type":"4"}},{"id":1739213,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-17T01:05:10.000Z","date":"2023-11-14","kind":"grant","planned":false,"acquired":true,"shares":26308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options were granted in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy on the effective date the Issuer appointed the Reporting Person to serve on its Board of Directors. One-third of these stock options are scheduled to vest on each of November 14, 2024, 2025 and 2026, assuming continued service through the applicable vesting date."}],"balance_after":26308,"derivative":{"exercise_price":1.07,"expiration_date":"2023-11-14","underlying":"Common Stock","underlying_shares":26308},"source":{"system":"sec-edgar","filing":"0001104659-23-119212","document":"tm2330756-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465923119212/tm2330756-2_4seq1.xml","form_type":"4"}},{"id":1739212,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T01:05:10.000Z","date":"2023-11-14","kind":"grant","planned":false,"acquired":true,"shares":177570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units were granted in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy on the effective date the Issuer appointed the Reporting Person to serve on its Board of Directors. One-third of these restricted stock units are scheduled to vest on each of November 14, 2024, 2025 and 2026, assuming continued service through the applicable vesting date."}],"balance_after":177570,"source":{"system":"sec-edgar","filing":"0001104659-23-119212","document":"tm2330756-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465923119212/tm2330756-2_4seq1.xml","form_type":"4"}},{"id":1778813,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-18T21:07:12.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":36072,"price":8.32,"value":300119.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.31 to $8.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":188730,"source":{"system":"sec-edgar","filing":"0001209191-23-049781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123049781/doc4.xml","form_type":"4"}},{"id":1958631,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance-based Restricted Stock Units","published_at":"2023-03-10T22:08:31.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":37118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."}],"balance_after":37118,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":37118},"source":{"system":"sec-edgar","filing":"0001209191-23-017878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123017878/doc4.xml","form_type":"4"}},{"id":1958630,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-10T22:08:31.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":74236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":152658,"source":{"system":"sec-edgar","filing":"0001209191-23-017878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123017878/doc4.xml","form_type":"4"}},{"id":2105151,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-23T21:05:49.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":6578,"price":11.56,"value":76041.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":78422,"source":{"system":"sec-edgar","filing":"0001209191-22-058611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919122058611/doc4.xml","form_type":"4"}},{"id":2480511,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-08T21:09:43.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as a new hire award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001209191-21-068513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121068513/doc4.xml","form_type":"4"}}]}